Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274M
-
Number of holders
-
292
-
Total 13F shares, excl. options
-
239M
-
Shares change
-
-3.86M
-
Total reported value, excl. options
-
$7.27B
-
Value change
-
-$103M
-
Put/Call ratio
-
0.52
-
Number of buys
-
158
-
Number of sells
-
-113
-
Price
-
$30.40
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q4 2017
356 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q4 2017.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 292 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 239M shares
of 274M outstanding shares and own 87.23% of the company stock.
Largest 10 shareholders include FMR LLC (36.4M shares), Vanguard Group Inc (26.4M shares), Meditor Group Ltd (16.5M shares), BlackRock Inc. (16.3M shares), GOLDMAN SACHS GROUP INC (14.8M shares), Matrix Capital Management Company, LP (10M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.98M shares), AQR CAPITAL MANAGEMENT LLC (7.33M shares), STATE STREET CORP (5.99M shares), and Invesco Ltd. (5.08M shares).
This table shows the top 292 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.